Journal article icon

Journal article

Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitis

Abstract:
Patient-reported quality-of-life (QoL) and carer impacts are not reported after leucine-rich glioma-inactivated 1-antibody encephalitis (LGI1-Ab-E). From 60 patients, 85% (51 out of 60) showed one abnormal score across QoL assessments and 11 multimodal validated questionnaires. Compared to the premorbid state, QoL significantly deteriorated (p < 0.001) and, at a median of 41 months, fatigue was its most important predictor (p = 0.025). In total, 51% (26 out of 51) of carers reported significant burden. An abbreviated five-item battery explained most variance in QoL. Wide-ranging impacts post-LGI1-Ab-E include decreased QoL and high caregiver strain. We identify a rapid method to capture QoL in routine clinic or clinical trial settings.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1002/acn3.52006

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Experimental Psychology
Role:
Author



Publisher:
Wiley
Journal:
Annals of Clinical and Translational Neurology More from this journal
Volume:
11
Issue:
4
Pages:
1053-1058
Publication date:
2024-02-01
Acceptance date:
2024-01-15
DOI:
EISSN:
2328-9503
ISSN:
2328-9503
Pmid:
38303486


Language:
English
Keywords:
Pubs id:
1611638
Local pid:
pubs:1611638
Deposit date:
2024-04-07

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP